Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)

By afschroeder • October 10, 2025

Shin AS, Xing Y, Waseem MR, Siwiec R, James-Stevenson T, Rogers N, Bohm M, Wo J, Lockett C, Gupta A, Kadariya J, Toh E, Anderson R, Dong A, Xu H, Gao X. Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS). Sci Rep. 2025 Oct 9;15(1):35375. doi: 10.1038/s41598-025-19363-2. PMID: 41068306; PMCID: PMC12511408.

Tags: Bile acid metabolism, Colonic microflora, Digestive Diseases, Functional gastrointestinal disorder, Gut-brain interaction, microbiome, Publications

Correction to: Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis

Lembo AJ, Chey WD, Harris LA, Frazier R, Brenner DM, Chang L, Lacy BE, Edelstein S, Yang Y, Zhao S, Rosenbaum DP. Correction to: Abdominal[...]

An IL-17-DUOX2 axis controls gastrointestinal colonization by Candida albicans

Kakade P, Burgueno JF, Sircaik S, Ponde NO, Li J, Ene IV, Kim J, Liang SH, Yunker R, Dey I, Akiba Y, Vaishnava S, Kaunitz[...]

A Note of Thanks to Lawrence Friedman: Editor and Mentor

Kaunitz J. A Note of Thanks to Lawrence Friedman: Editor and Mentor. Dig Dis Sci. 2026 May 1. doi: 10.1007/s10620-026-09871-0. Epub ahead of print. PMID:[...]